{"product_id":"george-washington-university-infectious-disease-board-review-course-2025","title":"George Washington University Infectious Disease Board Review Course 2025 (Lecture +PDF)","description":"\u003cstrong\u003eWARNING: The QBank section has 6 question sections with over 500 questions, with answers and detailed explanations, handcrafted into word files and converted to PDF by  . Includes access links to 8 lectures 2025 Infectious Disease Board Review Course Primers and Study Guides 8 PDF\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"724\" data-start=\"297\"\u003eThe \u003cem data-end=\"390\" data-start=\"323\"\u003eGWU Infectious Disease Board Review Course 2025\u003c\/em\u003e is a top-tier, all-in-one preparation bundle designed for physicians pursuing the infectious disease board certification. Featuring expertly crafted video lectures and a comprehensive question bank, this package offers both in-depth understanding and effective exam strategies—available entirely online to accommodate busy schedules.\u003c\/p\u003e\n\u003chr data-end=\"729\" data-start=\"726\"\u003e\n\u003cp data-end=\"756\" data-start=\"731\"\u003e\u003cstrong data-end=\"754\" data-start=\"731\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1386\" data-start=\"757\"\u003e\n\u003cli data-end=\"974\" data-start=\"757\"\u003e\n\u003cp data-end=\"974\" data-start=\"759\"\u003eCore concepts and high-impact updates across the field of infectious diseases, including antimicrobial therapy, HIV\/AIDS management, tropical medicine, endocarditis, opportunistic infections, and infection control\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1155\" data-start=\"975\"\u003e\n\u003cp data-end=\"1155\" data-start=\"977\"\u003eEffective strategies and diagnostic frameworks for challenging syndromes—such as sepsis, fever of unknown origin, transplant-associated infections, and antimicrobial resistance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1272\" data-start=\"1156\"\u003e\n\u003cp data-end=\"1272\" data-start=\"1158\"\u003eEvidence-based best practices and guidelines for patient-centered care in both inpatient and outpatient settings\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1386\" data-start=\"1273\"\u003e\n\u003cp data-end=\"1386\" data-start=\"1275\"\u003eTargeted board preparation with reinforced explanations through realistic, case-based multiple-choice questions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1391\" data-start=\"1388\"\u003e\n\u003cp data-end=\"1412\" data-start=\"1393\"\u003e\u003cstrong data-end=\"1410\" data-start=\"1393\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1899\" data-start=\"1413\"\u003e\n\u003cli data-end=\"1533\" data-start=\"1413\"\u003e\n\u003cp data-end=\"1533\" data-start=\"1415\"\u003e\u003cstrong data-end=\"1426\" data-start=\"1415\"\u003eFormat:\u003c\/strong\u003e Fully on-demand online delivery combining expert video lectures with a robust, interactive question bank\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1712\" data-start=\"1534\"\u003e\n\u003cp data-end=\"1712\" data-start=\"1536\"\u003e\u003cstrong data-end=\"1551\" data-start=\"1536\"\u003eComponents:\u003c\/strong\u003e Includes high-yield lecture modules, a question bank with detailed explanations, and downloadable study materials tailored to infectious disease board content\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1818\" data-start=\"1713\"\u003e\n\u003cp data-end=\"1818\" data-start=\"1715\"\u003e\u003cstrong data-end=\"1726\" data-start=\"1715\"\u003eAccess:\u003c\/strong\u003e Available across devices 24\/7, with flexible review timelines to suit your learning needs\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1904\" data-start=\"1901\"\u003e\n\u003cp data-end=\"2152\" data-start=\"1906\"\u003e\u003cstrong data-end=\"1927\" data-start=\"1906\"\u003eWho Should Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2152\" data-start=\"1906\"\u003eIdeal for infectious disease fellows, physicians preparing for board certification or recertification, advanced practice providers, and other healthcare professionals seeking a structured, high-yield review in ID medicine.\u003c\/p\u003e\n\u003chr data-end=\"2157\" data-start=\"2154\"\u003e\n\u003cp data-end=\"2504\" data-start=\"2159\"\u003e\u003cstrong data-end=\"2173\" data-start=\"2159\"\u003eWhy Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2504\" data-start=\"2159\"\u003eThis course is your most efficient and effective path to board success—combining comprehensive content, active learning, and flexible delivery.\u003c\/p\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch2 data-end=\"207\" data-start=\"153\"\u003e\u003cstrong data-end=\"207\" data-start=\"156\"\u003eDay 1 – Core Concepts \u0026amp; Immunocompromised Hosts\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"764\" data-start=\"208\"\u003e\n\u003cli data-end=\"235\" data-start=\"208\"\u003e\n\u003cp data-end=\"235\" data-start=\"210\"\u003eIntroduction \u0026amp; overview\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"276\" data-start=\"236\"\u003e\n\u003cp data-end=\"276\" data-start=\"238\"\u003eMicrobiology essentials for the exam\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"359\" data-start=\"277\"\u003e\n\u003cp data-end=\"359\" data-start=\"279\"\u003ePrinciples of antimicrobial therapy: toxicities, PK\/PD, drug–drug interactions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"431\" data-start=\"360\"\u003e\n\u003cp data-end=\"431\" data-start=\"362\"\u003eAntibacterial drugs I – approach to resistant gram-negative bacilli\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"451\" data-start=\"432\"\u003e\n\u003cp data-end=\"451\" data-start=\"434\"\u003eAntiviral drugs\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"542\" data-start=\"452\"\u003e\n\u003cp data-end=\"542\" data-start=\"454\"\u003eRespiratory viral infections including influenza (immunocompetent \u0026amp; immunocompromised)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"570\" data-start=\"543\"\u003e\n\u003cp data-end=\"570\" data-start=\"545\"\u003eSARS-CoV-2 and COVID-19\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"620\" data-start=\"571\"\u003e\n\u003cp data-end=\"620\" data-start=\"573\"\u003eImmunizations: domestic, travel, occupational\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"673\" data-start=\"621\"\u003e\n\u003cp data-end=\"673\" data-start=\"623\"\u003eInfections in hematopoietic stem cell recipients\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"722\" data-start=\"674\"\u003e\n\u003cp data-end=\"722\" data-start=\"676\"\u003eInfections in the neutropenic cancer patient\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"764\" data-start=\"723\"\u003e\n\u003cp data-end=\"764\" data-start=\"725\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"769\" data-start=\"766\"\u003e\n\u003ch2 data-end=\"822\" data-start=\"771\"\u003e\u003cstrong data-end=\"822\" data-start=\"774\"\u003eDay 2 – Hepatitis, GI \u0026amp; Parasitic Infections\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"1186\" data-start=\"823\"\u003e\n\u003cli data-end=\"842\" data-start=\"823\"\u003e\n\u003cp data-end=\"842\" data-start=\"825\"\u003eAcute hepatitis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"864\" data-start=\"843\"\u003e\n\u003cp data-end=\"864\" data-start=\"845\"\u003eChronic hepatitis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"903\" data-start=\"865\"\u003e\n\u003cp data-end=\"903\" data-start=\"867\"\u003eClinical immunology \u0026amp; host defense\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"928\" data-start=\"904\"\u003e\n\u003cp data-end=\"928\" data-start=\"906\"\u003eCMV, EBV, HHV6, HHV8\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"981\" data-start=\"929\"\u003e\n\u003cp data-end=\"981\" data-start=\"931\"\u003eAntibacterial drugs II – gram-positive organisms\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1011\" data-start=\"982\"\u003e\n\u003cp data-end=\"1011\" data-start=\"984\"\u003eGI infections Part I \u0026amp; II\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1047\" data-start=\"1012\"\u003e\n\u003cp data-end=\"1047\" data-start=\"1014\"\u003eHelicobacter and Clostridioides\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1083\" data-start=\"1048\"\u003e\n\u003cp data-end=\"1083\" data-start=\"1050\"\u003eSkin and soft tissue infections\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1118\" data-start=\"1084\"\u003e\n\u003cp data-end=\"1118\" data-start=\"1086\"\u003eProtozoa of clinical relevance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1144\" data-start=\"1119\"\u003e\n\u003cp data-end=\"1144\" data-start=\"1121\"\u003eWorms you should know\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1186\" data-start=\"1145\"\u003e\n\u003cp data-end=\"1186\" data-start=\"1147\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1191\" data-start=\"1188\"\u003e\n\u003ch2 data-end=\"1249\" data-start=\"1193\"\u003e\u003cstrong data-end=\"1249\" data-start=\"1196\"\u003eDay 3 – Fungal, Mycobacterial \u0026amp; Zoonotic Diseases\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"1677\" data-start=\"1250\"\u003e\n\u003cli data-end=\"1292\" data-start=\"1250\"\u003e\n\u003cp data-end=\"1292\" data-start=\"1252\"\u003eDeep mycoses (normal \u0026amp; abnormal hosts)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1336\" data-start=\"1293\"\u003e\n\u003cp data-end=\"1336\" data-start=\"1295\"\u003eNocardiosis, Actinomycosis, Rhodococcus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1396\" data-start=\"1337\"\u003e\n\u003cp data-end=\"1396\" data-start=\"1339\"\u003eTuberculosis (immunocompetent \u0026amp; immunosuppressed hosts)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1413\" data-start=\"1397\"\u003e\n\u003cp data-end=\"1413\" data-start=\"1399\"\u003eLyme disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1461\" data-start=\"1414\"\u003e\n\u003cp data-end=\"1461\" data-start=\"1416\"\u003eTicks, mites, lice and transmitted diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1474\" data-start=\"1462\"\u003e\n\u003cp data-end=\"1474\" data-start=\"1464\"\u003eZoonoses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1488\" data-start=\"1475\"\u003e\n\u003cp data-end=\"1488\" data-start=\"1477\"\u003ePneumonia\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1558\" data-start=\"1489\"\u003e\n\u003cp data-end=\"1558\" data-start=\"1491\"\u003eSexually transmitted infections (genital ulcers; other syndromes)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1609\" data-start=\"1559\"\u003e\n\u003cp data-end=\"1609\" data-start=\"1561\"\u003eSyndromes in the ICU relevant to ID physicians\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1635\" data-start=\"1610\"\u003e\n\u003cp data-end=\"1635\" data-start=\"1612\"\u003eHospital epidemiology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1677\" data-start=\"1636\"\u003e\n\u003cp data-end=\"1677\" data-start=\"1638\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1682\" data-start=\"1679\"\u003e\n\u003ch2 data-end=\"1717\" data-start=\"1684\"\u003e\u003cstrong data-end=\"1717\" data-start=\"1687\"\u003eDay 4 – HIV \u0026amp; Retroviruses\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"2216\" data-start=\"1718\"\u003e\n\u003cli data-end=\"1735\" data-start=\"1718\"\u003e\n\u003cp data-end=\"1735\" data-start=\"1720\"\u003eHIV diagnosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1759\" data-start=\"1736\"\u003e\n\u003cp data-end=\"1759\" data-start=\"1738\"\u003eHIV drug resistance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1818\" data-start=\"1760\"\u003e\n\u003cp data-end=\"1818\" data-start=\"1762\"\u003eAntiretroviral therapy (general \u0026amp; special populations)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1869\" data-start=\"1819\"\u003e\n\u003cp data-end=\"1869\" data-start=\"1821\"\u003eHIV-associated opportunistic infections I \u0026amp; II\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1917\" data-start=\"1870\"\u003e\n\u003cp data-end=\"1917\" data-start=\"1872\"\u003eNon–AIDS-defining complications of HIV\/AIDS\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1985\" data-start=\"1918\"\u003e\n\u003cp data-end=\"1985\" data-start=\"1920\"\u003eClinical manifestations of retroviral diseases and slow viruses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2004\" data-start=\"1986\"\u003e\n\u003cp data-end=\"2004\" data-start=\"1988\"\u003eHerpes simplex\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2037\" data-start=\"2005\"\u003e\n\u003cp data-end=\"2037\" data-start=\"2007\"\u003eBacterial \u0026amp; viral meningitis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2089\" data-start=\"2038\"\u003e\n\u003cp data-end=\"2089\" data-start=\"2040\"\u003ePharyngitis syndromes (including Group A strep)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2130\" data-start=\"2090\"\u003e\n\u003cp data-end=\"2130\" data-start=\"2092\"\u003eSyndromes masquerading as infections\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2174\" data-start=\"2131\"\u003e\n\u003cp data-end=\"2174\" data-start=\"2133\"\u003ePhoto review session: board-style cases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2216\" data-start=\"2175\"\u003e\n\u003cp data-end=\"2216\" data-start=\"2177\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2221\" data-start=\"2218\"\u003e\n\u003ch2 data-end=\"2274\" data-start=\"2223\"\u003e\u003cstrong data-end=\"2274\" data-start=\"2226\"\u003eDay 5 – Systemic \u0026amp; Device-Related Infections\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"2707\" data-start=\"2275\"\u003e\n\u003cli data-end=\"2334\" data-start=\"2275\"\u003e\n\u003cp data-end=\"2334\" data-start=\"2277\"\u003eEndocarditis (native \u0026amp; prosthetic valves, pacers, VADs)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2362\" data-start=\"2335\"\u003e\n\u003cp data-end=\"2362\" data-start=\"2337\"\u003eBone \u0026amp; joint infections\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2399\" data-start=\"2363\"\u003e\n\u003cp data-end=\"2399\" data-start=\"2365\"\u003eStaphylococcus aureus infections\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2457\" data-start=\"2400\"\u003e\n\u003cp data-end=\"2457\" data-start=\"2402\"\u003eNontuberculous mycobacteria (normal \u0026amp; abnormal hosts)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2498\" data-start=\"2458\"\u003e\n\u003cp data-end=\"2498\" data-start=\"2460\"\u003eInfections in solid organ recipients\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2552\" data-start=\"2499\"\u003e\n\u003cp data-end=\"2552\" data-start=\"2501\"\u003eEncephalitis (including West Nile virus \u0026amp; rabies)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2577\" data-start=\"2553\"\u003e\n\u003cp data-end=\"2577\" data-start=\"2555\"\u003ePenicillin allergies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2614\" data-start=\"2578\"\u003e\n\u003cp data-end=\"2614\" data-start=\"2580\"\u003eAntifungal drugs (core concepts)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2665\" data-start=\"2615\"\u003e\n\u003cp data-end=\"2665\" data-start=\"2617\"\u003e“Kitchen sink” syndromes not covered elsewhere\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2707\" data-start=\"2666\"\u003e\n\u003cp data-end=\"2707\" data-start=\"2668\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2712\" data-start=\"2709\"\u003e\n\u003ch2 data-end=\"2752\" data-start=\"2714\"\u003e\u003cstrong data-end=\"2752\" data-start=\"2717\"\u003eOnline-Only (OL) Bonus Lectures\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"3227\" data-start=\"2753\"\u003e\n\u003cli data-end=\"2823\" data-start=\"2753\"\u003e\n\u003cp data-end=\"2823\" data-start=\"2755\"\u003eHow to prepare for certification \u0026amp; recertification (including LKA)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2841\" data-start=\"2824\"\u003e\n\u003cp data-end=\"2841\" data-start=\"2826\"\u003eBootcamp: HIV\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2866\" data-start=\"2842\"\u003e\n\u003cp data-end=\"2866\" data-start=\"2844\"\u003eBootcamp: Transplant\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2896\" data-start=\"2867\"\u003e\n\u003cp data-end=\"2896\" data-start=\"2869\"\u003eStatistics for the boards\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2942\" data-start=\"2897\"\u003e\n\u003cp data-end=\"2942\" data-start=\"2899\"\u003eAntibacterial drugs not covered elsewhere\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2994\" data-start=\"2943\"\u003e\n\u003cp data-end=\"2994\" data-start=\"2945\"\u003eTreating antimicrobial-resistant infections III\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3042\" data-start=\"2995\"\u003e\n\u003cp data-end=\"3042\" data-start=\"2997\"\u003eHIV-associated opportunistic infections III\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3115\" data-start=\"3043\"\u003e\n\u003cp data-end=\"3115\" data-start=\"3045\"\u003eBrain abscess, cavernous sinus thrombosis, subdural\/epidural empyema\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3167\" data-start=\"3116\"\u003e\n\u003cp data-end=\"3167\" data-start=\"3118\"\u003eInfections of the urinary tract (upper \u0026amp; lower)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3207\" data-start=\"3168\"\u003e\n\u003cp data-end=\"3207\" data-start=\"3170\"\u003eEpididymitis, orchitis, prostatitis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3227\" data-start=\"3208\"\u003e\n\u003cp data-end=\"3227\" data-start=\"3210\"\u003eEven more worms\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954495524962,"sku":"MED-AMB04589","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Infectious-Disease-Board-Review-Course-2025_f6e00b10-54c4-40de-8a59-90dbc1bc9c10.png?v=1779378019","url":"https:\/\/meducourse.com\/products\/george-washington-university-infectious-disease-board-review-course-2025","provider":"Meducourse","version":"1.0","type":"link"}